Journal article
Mycophenolate Mofetil (CellCept®) for Psoriasis: A Two-Center, Prospective, Open-Label Clinical Trial
Abstract
Background: Mycophenolate mofetil (MMF) is an immune suppressant that selectively inhibits activated lymphocytes. Its usefulness in treating psoriasis has not been systematically investigated. Objective: To evaluate efficacy and safety of MMF as a monotherapy for psoriasis. Methods: This is a two-center, prospective, open-label clinical trial. Results: Twenty-three patients with moderate to severe psoriasis [mean psoriasis area and severity …
Authors
Zhou Y; Rosenthal D; Dutz J; Ho V
Journal
Journal of Cutaneous Medicine and Surgery, Vol. 7, No. 3, pp. 193–197
Publisher
SAGE Publications
Publication Date
July 2003
DOI
10.1007/s10227-002-0113-6
ISSN
1203-4754